The purpose of the Settlement Agreement is to settle all disputes pending between the parties that relate to the lawsuit filed on July 3, 2019 by the Company in the United States District Court for the Eastern District of Arkansas against the Selling Parties (the “Litigation”) in connection with the purchase by the Company of the assets of Golden Ridge on November 28, 2018 (the “Transaction”), and as further described in the Current Report on Form 8-K filed by the Company on July 9, 2019.

The Settlement Agreement provides for, among other things: dismissal of the Litigation, release to the Company of 340,000 shares of the Company’s common stock previously held in escrow in connection with the Transaction, discharge of the final payment of $358,000 owing by the Company in connection with the Transaction and a mutual release of all claims.

About RICEBRAN TECHNOLOGIES (NASDAQ:RIBT)

RiceBran Technologies is a human food ingredient, functional food ingredient, packaged functional food and animal nutrition company. The Company is focused on processing and marketing of nutrient dense products derived from raw rice, an underutilized by-product of the rice milling industry. The Company has two operating segments. The USA segment manufactures and distributes stabilized rice bran (SRB) (for human food ingredient and animal nutrition customers) and derivative products. The Brazil segment extracts crude rice bran oil (RBO) and defatted rice bran (DRB) from rice bran, which are then further processed into fully refined rice bran oil for sale internationally and in Brazil, compounded animal nutrition products for horses, cows, swine, sheep and poultry and a range of human food and animal nutrition products. The Brazil segment consists of the operations of Nutra S.A. LLC subsidiary, whose only operating subsidiary is Industria Riograndens De Oleos Vegetais Ltda. (Irgovel).